Danielle Líénard - Concepedia

Author

Danielle Líénard

Ludwig Cancer Research

Also Known As

D Lienard, D Liénard, Danielle Lienard, Danielle Liénard, Danielle Liènard, Danielle Liénard, Danielle Líénard

106

Publications

9.2K

Citations

H-Index

Concepts

All Affiliations

Ludwig Cancer Research University of Lausanne University Hospital of Lausanne Ludwig Cancer Research Université Libre de Bruxelles

About

Danielle Líénard is an author at Ludwig Cancer Research specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	32	3.3K
2	Cell Biology	16	17	1.5K
3	Allergy	6	6	945
4	Health Sciences	3	3	160
5	Diagnostic Sciences	1	1	13

Danielle Líénard

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909 Daniel E. Speiser, Danielle Líénard, Nathalie Rufer, Journal of Clinical Investigation	2005	621
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes Pedro Romero, P. Rod Dunbar, Danila Valmori, The Journal of Experimental Medicine	1998	515
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals Mikäel J. Pittet, Danila Valmori, P. Rod Dunbar, The Journal of Experimental Medicine HistocompatibilityAdaptive Immune SystemImmunologyImmune RegulationImmunodominance	1999	506
Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues Danila Valmori, Jean‐François Fonteneau, Concepción Marañón Lizana, The Journal of Immunology	1998	483
Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas Alexander M.M. Eggermont, Heimen Schraffordt Koops, Joseph M. Klausner, Annals of Surgery	1996	456
Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance Alfred Zippelius, Pascal Batard, Verena Rubio‐Godoy, Cancer Research	2004	363
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial Alexander M.M. Eggermont, Stefan Suciu, Rona M. MacKie, The Lancet Surgical OncologyOncologyMelanomaImmunologyClinical Trials	2005	310
Expression of <i>MAGE</i> genes in primary and metastatic cutaneous melanoma Francis Brasseur, Donata Rimoldi, Danielle Líénard, International Journal of Cancer	1995	285
Efficiency of recombinant human TNF in human cancer therapy. Ferdy J. Lejeune, Danielle Líénard, Maurice Matter, PubMed Tumor BiologySingle IlpAngiogenesisMedicineMelanoma	2006	263
In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes Daniel E. Speiser, Mikäel J. Pittet, Danila Valmori, The Journal of Experimental Medicine Cancer ImmunosurveillanceCell SignalingMedicineImmunologyTumor Immunity	1999	195

Page 1